Therapy-Related Myelodysplastic Syndrome Active Not Recruiting Phase 2 Trials for Sirolimus (DB00877)

IndicationStatusPhase
DBCOND0079186 (Therapy-Related Myelodysplastic Syndrome)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01885689Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic LeukemiaTreatment